WallStreetZenWallStreetZen

NASDAQ: POAI
Predictive Oncology Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Predictive Oncology revenue was $728.20k for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q3 2025) ending on Sep 30, 2025 was $3.6k, up 34.9% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, POAI annual revenue was $1.6M, with -0.2% growth year-over-year.

POAI past revenue growth

How has POAI's revenue growth performed historically?

Company
84.07%
Industry
13.68%
Market
22.91%
POAI's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
POAI's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
POAI's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

POAI revenue history

Current Revenue
$728.2k
Current Earnings
-$84.3M
Current Profit Margin
-11,581.3%

Be the first to know when POAI announces revenue.

POAI Revenue History By Year

POAI Yearly RevenuePOAI RevenuePOAI ChangePOAI Revenue Growth
2024-12-31$1.62M-$3.88k-0.24%
2023-12-31$1.63M$122.24k+8.12%
2022-12-31$1.51M$84.78k+5.97%
2021-12-31$1.42M$168.41k+13.45%
2020-12-31$1.25M-$159.29k-11.28%
2019-12-31$1.41M-$90.00-0.01%
2018-12-31$1.41M$756.82k+115.57%
2017-12-31$654.84k$198.34k+43.45%
2016-12-31$456.50k-$197.86k-30.24%
2015-12-31$654.35k-$297.21k-31.23%
2014-12-31$951.56k$483.43k+103.27%
2013-12-31$468.13k$279.35k+147.98%
2012-12-31$188.77k$92.14k+95.34%
2011-12-31$96.64k$96.35k+33,454.51%
2010-12-31$288.00-$15.45k-98.17%
2009-12-31$15.74kN/AN/A
2008-12-31$0.00N/AN/A
2007-12-31$0.00N/AN/A

1 of 2

Predictive Oncology Revenue FAQ

What was POAI's revenue last quarter?

Predictive Oncology (NASDAQ: POAI) reported Q3 2025 revenue of $3.62 thousand up 7.4% year over year. In the same quarter last year, Predictive Oncology's revenue was $3.91 thousand.

What was Predictive Oncology's revenue in 2024?

Predictive Oncology's annual revenue for the twelve months ending Dec 31, 2024 was $1.62 million, a 0.24% decrease year over year.

How much does Predictive Oncology make in a day?

Based on Predictive Oncology annual revenue for the past five years, POAI makes an average of $4,071.19 per day.

What was Predictive Oncology's annual revenue growth in the past year?

As of Q4 2025, Predictive Oncology's revenue has grown 84.07% year over year. This is 70.39 percentage points higher than the US Medical Instruments & Supplies industry revenue growth rate of 13.68%. Predictive Oncology's revenue in the past year totaled $728.20 thousand.

How much does Predictive Oncology make in a year?

Predictive Oncology's revenue by year for the past five years is:
  • Predictive Oncology's revenue for the twelve months ending Dec 31, 2024 was $1.62 million, a 0.24% decrease year over year.
  • Predictive Oncology's annual revenue for Dec 31, 2023 was $1.63 million, a 8.12% increase from 2022.
  • Predictive Oncology's annual revenue for 2022 was $1.51 million, a 5.97% increase from 2021.
  • Predictive Oncology's annual revenue for 2021 was $1.42 million, a 13.45% increase from 2020.
  • Predictive Oncology's annual revenue for 2020 was $1.25 million, a 11.28% decrease from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.